Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CAPS (Central Admixture Pharmacy Services) is the leading provider of outsourcing pharmacy services in the United States, specializing in the compounding of sterile preparations. As a subsidiary of B. Braun Medical, CAPS operates a large network of 503A regional pharmacies and 503B outsourcing facilities that provide custom-tailored solutions for hospitals and surgery centers. Their product portfolio includes parenteral nutrition (TPN), anesthesia syringes, cardioplegia solutions, and other critical care medications. The company is known for its high standards of quality and compliance with FDA and USP regulations, offering both daily delivery and long-term supply chain stability for healthcare providers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CAPS Pharmaceuticals.